RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ: RAPP · HEALTHCARE · BIOTECHNOLOGY
$33.00
-2.19% today
Updated 2026-04-29
Market cap
$1.58B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$8 – $42
Volume
0.3M
Rapport Therapeutics, Inc. Common Stock (RAPP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |